Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole SR vs IR for Nocturnal Symptoms in Advanced PD
NCT03521635Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pramipexole in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Started Jul 2018; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03521635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03521635.